+1.224.938.9523

HUMAN AMYLOID IMAGING CONFERENCE

January 16-18, 2019
Miami, Florida

HAI 2019 POSTER SESSIONS 


Click the “+” to open each module; tables can be sorted by clicking on each item of the header row (board number, poster title, authors and presenter, respectively).  Additionally, each table is searchable (use the search field located at the top right of each module).

Please note that we reserve the right to re-arrange the poster allocation.  The final version will be marked accordingly.

POSTER SESSION: 1 - Wednesday, January 16 - 2:00 - 3:30 pm
Board #Poster TitleAuthorsPresenter
1Novel PET radioligands show that COX-1 is constitutively expressed and COX-2 is upregulated by inflammationKim | Shrestha | Eldridge | Singh | Cortes | Hong | Morse | Gladding | Henry | Gallagher | Frankland | Tye | Liow | Zoghbi | Fujita | Pike | InnisKim
2Regression-based predictive features for clinical brain imagesClark | Del Gaizo | Goukasian | Hwang | ApostolovaApostolova
3Subcortical amyloid load is associated with volume and shape in cognitively normal individualsRahayel | Bocti | Sévigny Dupont | Joannette | Lavallée | Nikelski | Chertkow | JoubertRahayel
4Subcortical amyloid relates to cortical surface area in cognitively normal individualsRahayel | Bocti | Sévigny Dupont | Joannette | Lavallée | Nikelski | Chertkow | JoubertRahayel
5Global cortical network organization analysis of amyloid and tau across AD clinical spectrumQureshi | Pascoal | Mathotaarachchi | Benedet | Rosa-NetoQureshi
6Abnormal AV1451 signal in popular reference regionsSchwarz | Kantarci | Murray | Przybelski | Min | Lowe | Nedelska | Vemuri | Senjem | Gunter | Petersen | Knopman | JackSchwarz
7X-ray method for estimating amyloid load in the brainBadano | DahalBadano
8Impact of different image analysis methods on baseline 18F-Florbetapir PET measurements in the API ADAD Colombia trialGhisays | Chen | Protas | Goradia | Thiyyagura | Langbaum | Sink | Hu | Guthrie | Smith | Cho | Clayton | Thomas | Toga | Boker | Alvarez | Quiroz | Rios-Romenets | Chen | Su | Tariot | Lopera | ReimanGhisays
9Sub-threshold regional amyloid levels mediates parahippocampal thinning associated with reduced cerebral blood flow.Sisley | Sanchez | Domoto-Reilly | Grabowski | RaneRane
10[18F]GTP1 (Genentech tau probe 1) SUVR has a very little dependence on changes in regional or global cerebral blood flowSanabria | Baker | Marik | de Crespigny | WeimerSanabria
11Multimodal magnetic resonance imaging predicts regional cerebral amyloid burdenAlathur Rangarajan | Wu | Joseph | Karim | Laymon | Tudorascu | Snitz | Cohen | Mathis | Klunk | AizensteinAlathur Rangarajan
12Evaluation of [18F]APN-1607 to image tau protein in patients with Alzheimer’s disease and test-retest studiesSandiego | Barret | Carroll | Gouasmat | Madonia | Marek | Margolin | Tempest | JangSandiego
13Discovery of [18F]SMBT-1: a novel selective MAO-B PET tracer for imaging astrogliosisHarada | Ezura | Iwata | Arai | Yanai | Furumoto | Kudo | OkamuraHarada
14Effect of point spread function specification error on GTM partial volume correction in PiB imagingLaymon | Minhas | Kolibash | Aizenstein | Cohen | Lopresti | Mathis | Snitz | Tudorascu | KlunkLaymon
1511C-ER176 has superior quality than 11C-PBR28 to image brain inflammation with positron emission tomographyZanotti Fregonara | Pascual | Yu | Beers | Appel | MasdeuZanotti Fregonara
16Subject-specific site of maximum uptake is most sensitive to longitudinal change in 18F-AV1451 PET dataScott | Adamczuk | Gorman | Runkle | SuhyScott
17Functional connectivity of the entorhinal cortex predicts tau deposition in agingAdams | Maass | Harrison | JagustAdams
18A fully automatic technique for precise localization and quantification of amyloid-β PET scansTahmi | Bou Zeid | RazlighiRazlighi
19Network-based modeling of tau spread and seeding using PET and DTIYang | Chowdhury | Jacobs | Johnson | DuttaDutta
20Establishment of a simplified method to quantify [18F]PM-PBB3 ([18F]APN-1607) binding in the brains of living human subjectsSeki | Tagai | Shimada | Kitamura | Kimura | Ichise | Ono | Takahata | Kubota | Takado | Shinotoh | Okada | Kikuchi | Zhang | Suhara | HiguchiSeki
21PET and CSF amyloid status are differently predicted by patient featuresReimand | de Wilde | Teunissen | Zwan | Windhorst | Boellaard | van der Flier | Scheltens | van Berckel | Ossenkoppele | BouwmanReimand
22TauIQ – an algorithm to quantify global and local Tau accumulationWhittington | Seibyl | Hesterman | GunnGunn
23AmyloidIQ – an automated algorithm for classifying amyloid-β PET scansWhittington | Seibyl | Eichenlaub | Stephens | Hesterman | GunnWhittington
24Reconsidering in-vivo models of regional amyloid pathology progression: region-specific thresholds and longitudinal dataJelistratova | Bugla | Teipel | GrotheJelistratova
25Sensitivity of the standard Centiloid to track longitudinal amyloid-beta changes using 18F-Florbetaben PETBullich | Villemange | Koglin | Jovalekic | Perrotin | Doré | Stephens | Rowe | De SantiDe Santi
26Increased tau aggregation in young traumatic brain injury and post-concussion syndrome patientsLubberink | Wall | Vedung | Fahlström | Weis | Haller | Larsson | Antoni | MarklundLubberink
27Effect of blood flow changes on quantification of [18F]flutemetamol studiesHeeman | Yaqub | Lopes Alves | Heurling | Gispert | Foley | Boellaard | LammertsmaHeeman
28Longitudinal [18F]Flortaucipir in the BioFINDER 1 CohortSmith | Strandberg | Stomrud | HanssonSmith
29Preclinical characterization of two new promising tau PET tracers in vitro and in vivoSkaddan | Mugnaini | Guo | Wooten | Wilcox | Reuter | Voorbach | Montavon | Reed | Relo | Mezler | Haupt | Geneste | Erhard | Pohlki | Tovcimak | Finnema | Martarello | ComleyGuo
30Study on tissue-based and histogram-based reference regions for semi-quantitation of 18F-APN-1607 tau PET imagingHsiao | Huang | Chen | Lin | HuangHsiao
31Predicting amyloid accumulation in dominantly inherited Alzheimer's diseaseLuckett | McCullough | McCarthy | Hassenstab | Fagan | Schindler | McDade | Bateman | Benzinger | AncesLuckett
32Modeling the nonlinear effect of amyloid on cognitive impairment mediated by neurodegeneration in Alzheimer’s disease using path analysisKim | Shin | SeongKim
33IDentification and characterization of selective and high affinity small molecules for PET imaging of pathological alpha-synucleinCapotosti | Tsika | Molette | Ravache | Vokali | Rodriguez | Darmency | Piorkowska | Purohit | Paterson | Evans | Martarello | Salinas | Poli | Kroth | Stoehr | Lowe | Pfeifer | MuhsCapotosti
34APOE genotype is associated with specific regional patterns of amyloid accumulationKatz | Hanseeuw | Farrell | Moody | Sanchez | Mayblyum | Estime | Jacobs | Vannini | Sepulcre | Jiang | Schultz | Price | Sperling | JohnsonKatz
35Association of reported sleep-wake disturbances with tau pathology in mild cognitive impairment and normal cognitive agingShokouhi | Conley | Gwirtsman | NewhouseShokouhi
36Defining the lowest threshold for baseline amyloid-PET to predict future cognitive decline and amyloid accumulation in clinically normal adultsFarrell | Jiang | Schultz | Properzi | Rentz | Papp | Mormino | Betensky | Johnson | Sperling | BuckleyFarrell
37Mild behavioral impairment is associated with β-amyloid and tau in cognitively intact elderly individualsLussier | Pascoal | Chamoun | Therriault | Tissot | Savard | Kang | Mathotaarachchi | Benedet | Thomas | Parsons | Ismail | Rosa-Neto | GauthierLussier
38Evaluation of a visual read method for flortaucipir PET scansArora | Pontecorvo | Mintun | Fleisher | Devous | Lu | Galante | Stevenson | Flitter | Beach | Montine | Serrano | Sue | Intorcia | Curtis | Salloway | Thein | Wellman | Perrin | Lowe | Grossman | Irwin | Ikonomovic | Seeley | Rabinovici | MasdeuArora
39An MRI-free, template-based method for quantifying cortical florbetapir uptake in vivoKorman | Landau | JagustKorman
40Early increase in tau-PET signal is associated with changes in amyloid, CSF p-tau and cognitionMcSweeney | Pichet Binette | Meyer | Gonneaud | Bedetti | Ozlen | Daoust | Labonté | Rosa-Neto | Breitner | Poirier | VilleneuveMcSweeney
41Mental and physical activity during the 80-minute uptake time affects off-target binding in tau PET scans (18F-AV-1451)Apgar | Min | Maltais | Scott | Lecy | Lundt | Albertson | Schwarz | Botha | Jones | Kantarci | Vemuri | Knopman | Petersen | Jack | LoweMin
42Functional network changes occur prior to symptomatic conversion in ADWisch | Roe | Babulal | Benzinger | Morris | AncesWisch
43Enhancing tau signal of PET imaging using a convolutional autoencoderMathotaarachchi | Pascoal | Benedet | Chamoun | Savard | Kang | Therriault | Fonov | Gauthier | Rosa-NetoMathotaarachchi
44Co-evolving patterns of functional connectivity with amyloid and tau deposition in Alzheimer’s disease progressionSvaldi | Goñi | Amico | Risacher | Stage | West | Saykin | ApostolovaSvaldi
45Joint reconstruction method for longitudinal Tau-PET imagingTiss | Petibon | Ouyang | Ihsani | Kas | Habert | Johnson | El FakhriTiss
46Associations between Quantitative Susceptibility Mapping and measures of amyloid and tau in patients with Alzheimer's diseaseBaker | La Joie | Liu | Cobigo | Bourakova | Harrison | Rabinovici | JagustBaker
47The relationship between Aβ-related hippocampal activity and metabolism in impaired individualsScott | Hanseeuw | Huijbers | Hampton | Manning | Chhatwal | Buckley | Johnson | Sperling | SchultzScott
48Centiloid scale in practice: effect of different SUVR reference regions and comparison of Centiloid cut-offsAdamczuk | Sampat | Runkle | Gorman | Suhy | ScottAdamczuk
49Amyloid-beta imaging in glial cellsJethava | Prakash | ChopraJethava
50NODDI modeling reveals neurite orientation and dispersion differences in white matter tracts of beta-amyloid positive individualsHunt | Vogt | Dean, III | Betthauser | Christian | Johnson | Alexander | BendlinHunt
51Preliminary longitudinal evaluation of the novel tau tracer [18F]MK-6240Pascoal | Chamoun | Kang | Mathotaarachchi | Benedet | Therriault | Souvy | Gauthier | Rosa-NetoPascoal
POSTER SESSIONS: 2A - Thursday, January 17 - 10:15 - 11:00; 2B - Thursday, January 17, 4:45 - 5:30
Board #Poster TitleAuthorsPresenter
6018F-Florbetaben and 18F-Flutemetamol PET beta-amyloid binding expressed in centiloidsCho | Choe | Kim | Kim | Kim | Jang | Kim | Jung | Na | Park | SeoCho
61Modelling tau pathology progression in Alzheimer's disease: Preliminary results and parameters required at a minimum to inform the model.Soucy | Hortelan | BenaliSoucy
62Determination of FTD candidates in an MCI-SNAP cohort by PET amyloid and MRI structural analysisBuckley | Esteban | Wilkens | WolkBuckley
63Striatal amyloid load predicts conversion from aMCI to pADBuckley | Chedumbarum-Pillay | Jenkinson | Smith | Beach | Thal | WolkBuckley
64Evaluation of [18F]GTP1 (Genentech tau probe 1) Extent and Load for assessing tau burden in Alzheimer's diseaseSanabria Bohorquez | Baker | Manser | Toth | Marik | WeimerSanabria Bohorquez
65Novel tau PET ligand compound series for detecting 4-repeat tau lesionsKoga | Svensson | Sohn | DicksonKoga
66Comparable associations between memory impairment and hippocampal [18F]flortaucipir signal after optimizationWolters | Ossenkoppele | Golla | Verfaillie | Timmers | Visser | Tuncel | Coomans | Scheltens | Windhorst | van der Flier | Boellaard | van BerckelWolters
67Vascular medical treatment influences the association between vascular burden and amyloid pathology in middle-to-late-aged cognitively healthy individuals at risk for Alzheimer’s diseaseKöbe | Gonneaud | Pichet Binette | Meyer | McSweeney | Rosa-Neto | Breitner | Poirier | Villeneuve | (PREVENT-AD) Research GroupKöbe
68Amyloid deposition and hippocampal atrophy in non-demented elderly subjects over 85 yearsTreyer | Meyer | Buchmann | Crameri | Studer | Saake | Gruber | Unschuld | Nitsch | Hock | GietlTreyer
69Association between elevated brain tau pathology and subsequent cognitive decline among non-demented PSEN1 E280A mutation carriers: Preliminary findings from the COLBOS projectQuiroz | Sperling | Guzman-Velez | Hanseeuw | Pardilla-Delgado | Bocanegra | Vila-Castelar | Baena | Artola | Sanchez | Hampton | Fuller | Ramirez-Gomez | Gatchel | Schultz | Arboleda-Velasquez | Lopera | Reiman | JohnsonQuiroz
70[18F]AV1451 deposition pattern across the Alzheimer's disease spectrum – characterization at the individual levelPichet Binette | Gonneaud | Villeneuve | Neuroimaging InitiativePichet Binette
71BLAzER: A versatile and efficient workflow for analyzing PET neuroimaging data in Alzheimer's diseaseRaman | Grandhi | Murchison | Kennedy | Landau | Roberson | McConathyRaman
72Longitudinal 18F-APN-1607 (18F-PM-PBB3) PET in the rTg4510 mouse model of tauopathyHsiao | Huang | Lin | YangHsiao
73Healthy brain structural connectome predicts regional tau accumulation in amyloid-positive mild cognitive impairment patientsLee | Shin | Na | Seo | SeongLee
74Pearls and pitfalls of using centiloids in interventional anti-amyloid studies – an examination of amyloid reductions in the gantenerumab open label extension studiesKlein | Delmar | Abi-Saab | Andjelkovic | Ristic | Voyle | Hesterman | Seibyl | Marek | Baudler | Fontoura | DoodyKlein
75AV1451 and THK5351 PET with pathology correlations in a patient with Sporadic Creutzfeldt-Jakob DiseaseKim | Cho | Park | Jang | Ryu | Choi | Moon | Oh | Oh | Na | Lyoo | Kim | Choi | SeoKim
76Associations among amyloid, tau, cerebrovascular disease, and neurodegeneration across cognitive stages in the Alzheimer's continuumLao | Kreisl | BrickmanLao
77Association between neuroinflammation (level) and cognitive performanceThomas | Chamoun | Pascoal | Savard | Nazar | Sbeiti | Olmand | Mathotaarachchi | Kang | Therriault | Gauthier | Rosa-NetoThomas
78Relationship of amyloid-beta and neurofibrillary tau deposition in Down syndrome using [11C]PiB and [18F]AV-1451 PETZammit | Tudorascu | Cody | Laymon | Cohen | Minhas | Ellison | Sabbagh | Zaman | Johnson | Mathis | Klunk | Handen | ChristianZammit
79Amyloid accumulation in the striatum is more rapid than in the cortex early in Down syndrome and can serve as a marker for early interventionZammit | Cody | Betthauser | Tudorascu | Lao | Laymon | Cohen | Murali | Minhas | Zaman | Johnson | Mathis | Klunk | Handen | ChristianZammit
80Cross-sectional associations between temporal tau and cortical thickness across the lifespanMoody | Jacobs | Sidwell | Hanseeuw | Katz | Sanchez | Mayblyum | Estime | Sepulcre | Satizabal | Pase | Beiser | Demissie | Daniluk | Schaefer | Peets | Price | Sperling | DeCarli | Seshadri | JohnsonMoody
81Amyloid-dependent and –independent effects of Tau on clinical function in Alzheimer's diseaseTherriault | Pascoal | Sefranek | Mathotaarachchi | Savard | Benedet | Chamoun | Kang | Gauthier | Rosa-NetoTherriault
82In-vivo tau burden correlates with subregional atrophy in medial temporal lobe in amyloid negative individualsDas | Xie | Wisse | Cui | Ittyerah | Yushkevich | WolkDas
83Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer’s diseaseOssenkoppele | Lyoo | Rabinovici | HanssonOssenkoppele
84Item-level analysis of the Cognitive Function Index by screening amyloid PET in the A4 StudyAmariglio | Sikkes | Marshall | Buckley | Gatchel | Johnson | Rentz | Donohue | Raman | Sun | Yaari | Holdridge | Grill | Aisen | SperlingAmariglio
85Cross-sectional and longitudinal effects of asymmetric amyloid deposition on memory in Baltimore Longitudinal Study of Aging (BLSA) participantsBrinson | Bilgel | An | Huang | Wong | ResnickBrinson
86Voxel-wise receiver operating characteristic analysis reveals clinically relevant sites of amyloid-Beta depositionTherriault | Pascoal | Leuzy | Collij | Lessa Benedet | Mathotaarachchi | Kang | Alves | Massarweh | Soucy | Gauthier | Rosa-NetoTherriault
87Regional sex-differences in tau pathology in asymptomatic individuals with elevated amyloidJacobs | Buckley | Mormino | Schultz | Raman | Donohue | Sun | Marek | Seibyl | Mintun | Shcherbinin | Pontecorvo | Rowe | VanDyck | Salloway | Jack | Yaari | Holdridge | Aisen | Sperling | JohnsonJacobs
88CSF tau biomarkers correlate with [18F]MK6240 SUVR in Alzheimer’s disease related areasChamoun | Kang | Pascoal | Benedet | Mathotaarachchi | Therriault | Savard | Thomas | Bouhachi | Hsiao | Massarweh | Soucy | Gauthier | Rosa-NetoChamoun
89Diagnostic accuracy of [18F]RO948 PET for differentiating Alzheimer’s disease from other neurodegenerative disordersHansson | Stomrud | Borroni | Klein | Strandberg | SmithHansson
90Amyloid burden and hippocampal functionBeason-Held | Shafer | Bilgel | Wong | ResnickBeason-Held
91Ante-post mortem binding of THK5317 and its vitro comparability with MK-6240 in a case of FTLDLemoine | Chiotis | Leuzy | Graff | Nennesmo | NordbergLemoine
92Tau and amyloid protein accumulation affect distinct White Matter fiber tracts in Alzheimer's DiseaseSavard | Kang | Pascoal | Mathotaarachchi | Therriault | Chamoun | Lessa Benedet | M. Thomas | Parsons | Tissot | Lussier | Gauthier | Rosa-NetoSavard
93Plasma neurofilament light chain concentrations in relation to [18F]florbetapir and [18F]flortaucipir PET in Alzheimer's diseaseLessa Benedet | Leuzy | A. Pascoal | Mathotaarachchi | Savard | Therriault | Kang | Chamoun | Schöll | J. Ashton | Gauthier | Zetterberg | Rosa-Neto | Blennow | for the Alzheimer’s Disease Neuroimaging InitiativeSavard
94APOEε4 potentiates the relationship between amyloid-β and tau pathologies in a dose-dependent mannerParsons MD, CM | Therriault BSc | Benedet MSc | Pascoal MD | Mathotaarachchi MSc | Savard BSc | Kang BSc | Chamoun PhD | Soucy MD, MSc | Massarweh PhD | Saha-Chaudhuri PhD | Poirier PhD | Gauthier MD, FRCPC | Rosa-Neto MD, PhD, for the Alzheimer’s Disease Neuroimaging InitiativeParsons
95Quantitative gradient recalled echo (qGRE) MRI identifies significant neuronal loss in the hippocampal subfields related to cognitive impairment in mild Alzheimer's diseaseKothapalli | Benzinger | Hassenstab | Goyal | Morris | YablonskiyKothapalli
96Predictors for β-amyloid positivity in cognitively impaired patients. Data from the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) StudyLesman-Segev | Hanna | La Joie | Iaccarino | Siegel | Hillner | Whitmer | Carrillo | Edwards | Chaudhary | Gatsonis | RabinoviciLesman-Segev
97Regional tau and atrophy: domain-specific relationships with cognitionDigma | Reas | Brewer | BanksBanks
98Inferior temporal tau is associated with greater prospective cortical thinning in clinically-normal older adultsHampton | Scott | Buckley | Chhatwal | Jacobs | Hanseeuw | Johnson | Sperling | SchultzHampton
99Lower left ventricular ejection fraction relates to increased cerebrospinal fluid biomarker evidence of neurodegeneration in older adultsKresge | Liu | Gupta | Osborn | Acosta | Bell | Pechman | Gifford | Mendes | Wang | Blennow | Zetterberg | Hohman | JeffersonKresge
100ApoE4 as a moderating factor between mild traumatic brain injury and tau deposition in the temporal cortexMunro | Chen | Rundle | Cullum | Rodrigue | ParkMunro
101A longitudinal examination of amyloid burden and myelin content in major white matter tractsYang | Dean III | Vogt | Jonaitis | Hunt | Merluzzi | Kohli | Christian | Oh | Betthauser | Asthana | Johnson | Alexander | BendlinYang
102Amyloid-β and cortical atrophy in adults with Down syndromeCody | Tudorascu | Lao | Cohen | Zaman | Laymon | Johnson | Klunk | Handen | ChristianCody
103Initial Clinical Evaluation of [18F] PI-2620 as a potent Positron Emission Tomography radiotracer imaging tau proteinOh | Oh | Lee | Oh | Roh | Chung | Lee | Lee | KimOh
104Asymmetric tau and focal amyloid PET in an autopsy-confirmed case of Alzheimer’s disease presenting as primary progressive aphasiaMartersteck | Sridhar | Coventry | Mesulam | RogalskiMartersteck
105Sex-specific effects of APOE-e4 genotype on amyloid burden and cognitive functionIsenberg | Aslanyan | PaIsenberg
106Relationship between intracranial blood flow and beta-amyloid assessed with PiB PETCody | Betthauser | Koscik | Rivera-Rivera | Berman | Cary | Hoffman | Clark | Chin | Barnhart | Bendlin | Johnson | Wieben | Christian | JohnsonCody
107Personalizing the use of the ATN framework in clinical research: integrating the clinical phenotype and biomarkers in a case series across the MCI/dementia spectrumDickerson | McGinnis | Quimby | Hochberg | Brickhouse | Collins | Putcha | Eldaief | Wong | Frosch | Das | McMillan | Yuschkevich | de Flores | Wisse | Xie | WolkDickerson
108The ATN framework in ADNI: How do different A,T, and N biomarkers influence the definition of AD pathology and cognitive trajectories?Landau | Korman | Shaw | Trojanowski | JagustLandau
109Neuropsychiatric symptoms are correlated with tau deposition in the Alzheimer’s disease spectrumTissot | Pascoal | Therriault | Chamoun | Lussier | Savard | Mathotaarachchi | Lessa Benedet | Thomas | Parsons | Rosa-Neto | GauthierTissot
110Amyloid-sex interaction effect on cognitive decline: Differential effects on memory versus executive functioning are not mediated by temporal lobe atrophyGavett | Fletcher | Mungas | DeCarliDeCarli
111Molecular imaging discordance with CSF AD biomarkers in atypical Alzheimer's diseaseTownleyTownley
POSTER SESSIONS: 3A - Friday, January 18, 10:00 - 10:45; 3B - Friday, January 18, 4:15 - 5:00
Board #Poster TitleAuthorsPresenter
120Longitudinal [18F]AV-1451 PET imaging in primary progressive apraxia of speechUtianski | Martin | Schwarz | Hugo | Duffy | Petersen | Clark | Machulda | Butts | Jack, Jr. | Lowe | Whitwell | JosephsUtianski
121Disease progression modeling from preclinical stages of Alzheimer's disease to AD dementiaCho | Woo | Kim | Kim | Kim | Kim | Jang | Kim | Kim | Jung | Kim | Lockhart | Ossenkoppele | Landau | Jagust | Weiner | Na | SeoCho
122Metabolism mediates the effect of tau on cognition in mild cognitive impairment and dementiaRodriguez-Vieitez | Mazrina | Chiotis | Colato | NordbergRodriguez-Vieitez
123Patterns of cerebral tau deposition across Alzheimer's disease stages: A study comparing 18F-THK5317 and 18F-AV-1451 PET tracersRodriguez-Vieitez | Colato | Chiotis | Mazrina | NordbergRodriguez-Vieitez
124Association of subjective cognitive decline and gait slowing with Aβ deposition in cognitively normal individualsNadkarni | Perera | Snitz | Mathis | DeKosky | Klunk | LopezNadkarni
125Cerebrospinal fluid synaptic vesicle glycoprotein 2A in Alzheimer's diseaseAshton | Höglund | Leuzy | Heurling | Hansson | Schöll | Zetterberg | BlennowAshton
126Longitudinal evaluation of [18F]MK-6240 in Alzheimer's disease and cognitively normal adults: preliminary results at 6 and 12 monthsSalinas | Purohit | Lohith | Struyk | Martarello | BeaverSalinas
127Subicular volume as a surrogate marker of beta-amyloid associated episodic memory variation at high ageSchroeder | Van Bergen | Schreiner | Meyer | Kagerer | Vionnet | Gietl | Treyer | Buck | Kaufmann | Nitsch | Pruessmann | Hock | UnschuldUnschuld
128Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markersJang | Jang | Kim | Werring | Lee | Choe | Park | Lee | Kim | Kim | Cho | Kim | Kim | Charidimou | Na | SeoJang
129Tau deposition in amyloid negative subjects: the application of the AT(N) model in the Geneva Memory Center experienceDodich | Frisoni | Andryszak | Scheffler | Mendes | Assal | Schibli | Schwarz | Rakotomiaramanana | Gold | Zekry | Lovblad | Chicherio | Boccardi | Unschuld | GaribottoDodich
130Characterizing the spatial distribution of cross-sectional [18F]GTP1 (Genentech tau probe 1) SUVR using multivariate statistical analysis and machine learningManser | Sanabria Bohorquez | Baker | Toth | Teng | Marik | WeimerManser
131Spatially compact components of non-negative matrix factorization applied to AV-1451 PET images reveal distinct demographic associationsBilgel | Ziontz | Shafer | Wong | ResnickBilgel
132Independent contributions of hippocampal activity, amyloid burden, and retrospective decline to Subjective Cognitive DeclineChen | Jingting | Farrell | ParkChen
133Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivityPereira | Ossenkoppele | Palmqvist | Strandberg | Smith | Westman | HanssonPereira
134Influence of apolipoprotein-E (APOE) genotype on amyloid trajectories in a longitudinal subject cohortLopresti | Campbell | Yu | Snitz | Anderson | Aizenstein | Minhas | Kolibash | Cohen | Mathis | Klunk | Lopez | TudorascuLopresti
135A follow-up report on the prevalence and magnitude of amyloid positivity between cognitively normal elderly Japanese and AmericansYu | Lopresti | Ihara | Cui | Aizenstein | Higashiyama | Fukuda | Koizumi | Minhas | Lopez | Klunk | Mathis | Miyamoto | Kuller | SekikawaLopresti
136Association of in vivo [F-18]AV-1451 with [C-11]PiB, [F-18]FDG hypometabolism, and cortical atrophy in chronic TBI subjectsMinhas | Mountz | Laymon | Lopresti | Beers | Sharpless | Puccio | Edelman | Mathis | OkonkwoMinhas
137Staging cortical amyloid deposition using PET imagingCollij | Heeman | Salvadó | Altomare | de Wilde | Konijnenberg | van Buchem | Yaqub | Markiewicz | Golla | Wottschel | Wink | Visser | Lammertsma | Scheltens | van der Flier | Boellaard | van Berckel | Gispert | Schmidt | Barkhof | Lopes Alves | AMYPAD consortiumCollij
138PET analysis of verubecestat effect on amyloid load in mild-to-moderate Alzheimer's disease patients (EPOCH trial)Sur | Adamczuk | Sampat | Kost | Scott | Suhy | EganSur
139Effect of verubecestat on amyloid load in prodromal Alzheimer's disease patients: Results from the PhIII APECS trialSur | Kost | Adamczuk | Scott | Suhy | EganSur
140AV1451 retention is associated with hippocampal volume and memory declines in cognitively normal older adultsZiontz | Bilgel | Shafer | June | Wong | ResnickZiontz
141[11C]PIB PET is associated with the brain biopsy amyloid β load and CSF amyloid β levels in subjects with normal pressure hydrocephalusRinne | Suotunen | Rummukainen | Herukka | Nerg | Koivisto | Rauramaa | Nagren | Hiltunen | Alzfuzoff | Rinne | Jääskeläinen | Soininen | LeinonenRinne
142The BIN1 rs744373 SNP is associated with increased tau-PET levels and worse memory independent of amyloidFranzmeier | Neitzel | Rubinski | EwersFranzmeier
143Optimal scanning time for the Novel Tau PET Tracer 18F-APN-1607Huang | Hsiao | Lin | Lian | Hsu | HuangHuang
144Associations between behavioral factors and Alzheimer's pathology: Findings from cognitively normal older adults at risk of AD and presymptomatic ADAD mutation carriersPichet Binette | Gonneaud | Ozlen | Bedetti | Morris | Bateman | Benzinger | Poirier | Breitner | Villeneuve | Research Group | Study GroupPichet Binette
145Early localized network dysfunction in APOE ε4 carriers without biomarker evidence of Alzheimer's diseaseButt | Strain | Wisch | Schindler | Fagan | Curchaga | Benzinger | AncesButt
146Association between retinal thickness and brain β-amyloid accumulation in individuals with Subjective Cognitive Decline: data from the FACEHBI studyMarquié | Monté-Rubio | Rodríguez-Gómez | Sanabria | Castilla-Martí | Martínez | Alegret | Pérez-Cordón | Lomeña | Pavia | Gismondi | Bullich | Vivas-Larruy | Tejero | Gómez-Chiari | Orellana | Valero | Ruiz | Tárraga | BoadaMarquié
147Image features and clinical associations of the novel tau PET tracer 18F-APN-1607 in Alzheimer's diseaseHsu | Lin | Hsiao | Lian | Huang | Huang | YenHsu
148Safety, Biodistribution and Radiation Dosimetry for the Tau PET Tracer 18F-APN-1607 in Healthy Human SubjectsLin | Hsiao | Lian | Huang | Hsu | Huang | YenLin
149Comparing Amyloid PET Tracers and Interpretation Strategies: A Multicenter StudyBischof | Bartenstein | Barthel | van Berckel | Doré | van Eimeren | Forster | Hammes | Lammertsma | Minoshima | Rowe | Sabri | Seibyl | van Laere | Vandenberghe | Villemagne | Yakushev | DrzezgaBischof
150Longitudinal associations between Aβ and glucose metabolism in a normal elderly populationTudorascu | Yu | Anderson | Snitz | Minhas | Laymon | Lopresti | Mathis | Aizenstein | Klunk | CohenCohen
151Associations between Aβ, tau, and cerebrovascular reactivity in a non-demented elderly populationCohen | Huppert | Tudorascu | Snitz | Laymon | Lopresti | Mathis | Nadkarni | Lopez | Aizenstein | Klunk | ReisCohen
152Amyloid and memory impairment have additive effects on microglial activation but not tau pathologyKreisl | Tao | Zou | Johnson | Tomljanovic | Razlighi | Brickman | Lee | SternKreisl
153A preliminary analysis of the association between cerebral blood flow and amyloid and tau PET binding in older adultsAlbrecht | Isenberg | Stradford | Monreal | Jann | PaAlbrecht
154Random forests of amyloid PET may pinpoint key brain regions predictive of MoCA scoreZukotynski | Gaudet | Kuo | Adamo | Goubran | Scott | Bocti | Borrie | Chertkow | Frayne | Hsiung | Laforce | Noseworthy | Prato | Sahlas | Smith | Sossi | Thiel | Soucy | Tardif | BlackZukotynski
155Comparison of objective and self-reported sleep, tau, and Aβ in healthy older adultsWiner | Fenton | Harrison | Maass | Baker | JagustWiner
156Relation of cardiovascular risk factors to markers of pathology and memory in autosomal-dominant Alzheimer's diseaseMartínez | Guzmán-Vélez | Padilla-Delgado | Vila-Castelar | Fuller | Artola | Sperling | QuirozGuzmán-Vélez
157Beta-Amyloid Accumulation in Non-demented elderly Individuals correlates with baseline Beta-amyloid Load, ApoE Genotype and AgeGietl | Treyer | Buchmann | Meyer | Saake | Gruber | Mu | Unschuld | Buck | Nitsch | HockGietl
158Identification of rapid amyloid accumulators: A longitudinal PET amyloid studyKoychev | Vaci | Bilgel | An | Albert | ResnickKoychev
159Age-of-onset dependent associations between [18F]Flortaucipir PET and cognitive impairment in Alzheimer's diseaseVisser | Wolters | Verfaillie | Ossenkoppele | Timmers | Tuncel | Golla | Boellaard | Windhorst | Scheltens | van der Flier | van BerckelVisser
160Deriviation of amyloid PET centiloid cut-offs using core AD CSF biomarkers including the whole Alzheimer's continuum: a joint analysis in ALFA and ADNISalvadó | Brugulat-Serrat | Falcon | Pavia | Niñerola | Perissinotti | Lomeña | Zetterberg | Blennow | Molinuevo | Gispert | ADNI, TRIBEKA Consortium and ALFA studySalvado
161SSRI Reduces CSF Aβ42 in healthy older adults and transgenic mice: dose, duration and baseline amyloid effectsSheline | Snider | Lee | Linn | Fagan | Yan | Aselcioglu | Waligorska | Korecka | Morris | Shaw | CirritoSheline
162Determination of the optimal scanning time point for the assessment of tau deposition in Alzheimer's disease using [18F]PI-2620 PETBullich | Mueller | Barret | Berndt | Madonia | Seibyl | Marek | StephensStephens
163Prediction of brain age using resting-state functional connectivity suggests accelerated aging in the preclinical phase of autosomal dominant Alzheimer's disease, irrespectively of amyloid pathologyGonneaud | Vachon-Presseau | Baria | Pichet Binette | Benzinger | Morris | Bateman | Breitner | Poirier | Villeneuve | Study Group | Research GroupGonneaud
164Vascular risk factors and multimodal neuroimaging biomarkers: Preliminary analyses from a biracial older adult cohortLockhart | Craft | Sachs | Rapp | Jung | Whitlow | Hayden | HughesLockhart
165Chronic low-grade inflammation associates with lower TSPO binding in elderly individuals without dementiaEkblad | Toppala | Tuisku | Helin | Marjamäki | Laine | Jula | Viitanen | RinneEkblad
166Cognitive trajectory of subcortical vascular cognitive impairmentKim | Woo | Jang | Cho | Kim | Lee | Kim | Kim | Lee | Kim | SeoKim
167F18-PI2620 Tau PET in Three Memory Clinic Patients with Uncertain CSF Biomarker ProfilesFrolov | Sha | Fredericks | Nadiadwala | Azevedo | Hall | Toueg | Castillo | Deutsch | Greicius | Davidzon | Zaharchuk | Chin | MorminoFrolov
168Differential associations of cortisol plasma level with glucose metabolism, hippocampal atrophy, and amyloid deposition across Alzheimer's disease stagesOh | Leung | Canli | SlifsteinOh
169Cerebral small vessel disease is associated with medial temporal lobe hyperconnectivity in pre-clinical ADWu | Tudorascu | Mathis | Lopresti | Cohen | Snitz | Klunk | AizensteinWu
170The Epicenter of Agrammatic / Non-Fluent Primary Progressive Aphasia Has the Greatest Syntactic Network Node Centrality in Healthy IndividualsFunk | Rockers | Zanotti-Fregonara | Masdeu | PascualFunk
171Modeling PiB PET trajectory groups identifies a subgroup with PiB beta-amyloid accumulation near age 50 and predicts MK-6240 SUVRKoscik | Betthauser | Jonaitis | Clark | Allison | Mueller | Hermann | Poetter | Sanson | Shouel | Chin | Christian | JohnsonKoscik

2018 Poster Sessions